The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...

However, the Mariners simply cannot stop trying. With arguably the best starting rotation in the sport, all it will take is ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced upcoming presentations of six posters highlighting data from their ...

IND cleared by FDA and dosing in the Phase 1 clinical trial initiated, with data expected in the first half of 2025Sanofi ...

Background TLR 7/8 are transmembrane receptors that recognize single-stranded RNA. In humans, TLR7 is mainly expressed in B cells and plasmacytoid dendritic cells and its activation stimulates ...

Harper, an 8-year-old, has McCune-Albright syndrome, a rare bone disease that softens her joints to the point that metal rods are needed to provide stability. A doctor at the National Institute of ...

A diverse workforce brings a range of skills, perspectives, and experiences that drive innovation and problem-solving, which in turn can lead to enhanced decision-making and improved business ...

TLR antagonists are being investigated for the treatment of inflammatory diseases. Examples here include the inhibition of TLR7 and TLR9 in systemic lupus erythematosus, inhibition of TLR4 in ...

Dysregulated neutrophil activation plays a significant role in sepsis. This study shows that the membrane protein CMTM3 is ...

The G 550 returns with what some call “mild hybrid” technology, or MHEV. In addition to the turbocharged 3.0L inline six-cylinder, a 48-volt integrated starter generator adds extra torque ...